Antibiotic-Coated Intramedullary Nailing Managing Long Bone Infected Non-Unions: A Meta-Analysis of Comparative Studies.
Amirhossein Ghaseminejad-RaeiniAlireza AzarbooKasra PiraheshAmirmohammad SharafiAmir Human HoveidaeiBasilia Onyinyechukwu NwankwoAbhijith AnnasamudramJanet D ConwayPublished in: Antibiotics (Basel, Switzerland) (2024)
Long bone infected non-unions are such an orthopedic challenge that antibiotic-coated intramedullary nailing (ACIN) has become a viable therapeutic option for their management. This study aims to provide a comprehensive assessment of the available data about the use of antibiotic-coated nailing in the treatment of long bone infected non-unions. Following the PRISMA guideline in this meta-analysis, a systematic literature search was conducted across major databases for studies evaluating ACIN in long bone infected non-unions. The primary outcome measures included union rates, infection control, complications and functional status. Five eligible studies encompassing 183 patients in total met the inclusion criteria. The meta-analysis revealed no difference in the union rate in the antibiotic-coated intramedullary nailing group compared to that of the control group (OR = 1.73 [0.75-4.02]). Antibiotic-coated intramedullary nailing demonstrated no association with higher infection eradication (OR = 2.10 [0.97-4.54]). Also, functional outcome measure was mostly not significantly different between ACIN and control interventions. According to this meta-analysis, compared to the management of controls, ACIN is neither linked to increased union rates nor decreased infection rates. The paucity of research on this topic emphasizes the continuous need for additional well-designed randomized controlled trials for the application of antibiotics-coated intramedullary nailing in long bone non-unions.
Keyphrases
- systematic review
- case control
- bone mineral density
- meta analyses
- soft tissue
- bone loss
- randomized controlled trial
- bone regeneration
- postmenopausal women
- ejection fraction
- newly diagnosed
- end stage renal disease
- physical activity
- big data
- body composition
- helicobacter pylori infection
- single cell
- electronic health record
- clinical trial
- machine learning
- smoking cessation
- helicobacter pylori
- replacement therapy